Reata Pharmaceuticals, Inc.
Reata Pharmaceuticals, Inc. (RETA) Stock Overview
Explore Reata Pharmaceuticals, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
6.6B
P/E Ratio
-20.07
EPS (TTM)
$-2.60
ROE
0.47%
RETA Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Reata Pharmaceuticals, Inc. (RETA) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $0.00.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -20.07 and a market capitalization of 6.6B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.